nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advances in ICD Lead Technology
|
John M. Herre |
|
2001 |
5 |
1 |
p. 46-50 5 p. |
artikel |
2 |
Advances in ICD Lead Technology
|
Herre, John M. |
|
2001 |
5 |
1 |
p. 46-50 |
artikel |
3 |
Automated External Defibrillators: Recent Developments and Lessons from Airline and Casino Experiences
|
Richard L. Page |
|
2001 |
5 |
1 |
p. 31-34 4 p. |
artikel |
4 |
Automated External Defibrillators: Recent Developments and Lessons from Airline and Casino Experiences
|
Page, Richard L. |
|
2001 |
5 |
1 |
p. 31-34 |
artikel |
5 |
Comparative Features, Functions and Longevities ofImplantable Cardioverter Defibrillators
|
Mohammad Saeed |
|
2001 |
5 |
1 |
p. 40-45 6 p. |
artikel |
6 |
Comparative Features, Functions and Longevities of Implantable Cardioverter Defibrillators
|
Saeed, Mohammad |
|
2001 |
5 |
1 |
p. 40-45 |
artikel |
7 |
Complications in the Implantation of Dual-ChamberICD
|
Erol M. Kosar |
|
2001 |
5 |
1 |
p. 107-108 2 p. |
artikel |
8 |
Complications in the Implantation of Dual-Chamber ICD
|
Kosar, Erol M. |
|
2001 |
5 |
1 |
p. 107-108 |
artikel |
9 |
Controversial Indications for ICD Therapy
|
Peter Geelen |
|
2001 |
5 |
1 |
p. 15-17 3 p. |
artikel |
10 |
Controversial Indications for ICD Therapy
|
Geelen, Peter |
|
2001 |
5 |
1 |
p. 15-17 |
artikel |
11 |
Cost-Effectiveness of the Implantable CardioverterDefibrillator
|
Mark A. Hlatky |
|
2001 |
5 |
1 |
p. 104-106 3 p. |
artikel |
12 |
Cost-Effectiveness of the Implantable Cardioverter Defibrillator
|
Hlatky, Mark A. |
|
2001 |
5 |
1 |
p. 104-106 |
artikel |
13 |
Dual Chamber Implantable Cardioverter-Defibrillators: Should They Always bePreferred to Single Chamber Cardioverter-Defibrillators?
|
Massimo Santini |
|
2001 |
5 |
1 |
p. 18-23 6 p. |
artikel |
14 |
Dual Chamber Implantable Cardioverter-Defibrillators: Should They Always be Preferred to Single Chamber Cardioverter-Defibrillators?
|
Santini, Massimo |
|
2001 |
5 |
1 |
p. 18-23 |
artikel |
15 |
Editorial: The Implantable Cardioverter Defibrillator in Its 20thYear
|
David S. Cannom |
|
2001 |
5 |
1 |
p. 5-5 1 p. |
artikel |
16 |
Editorial: The Implantable Cardioverter Defibrillator in Its 20th Year
|
Cannom, David S. |
|
2001 |
5 |
1 |
p. 5 |
artikel |
17 |
Environmental Interference and Interactions withImplantable Cardioverter-Defibrillator Functions
|
James J. Putzke |
|
2001 |
5 |
1 |
p. 114-116 3 p. |
artikel |
18 |
Environmental Interference and Interactions with Implantable Cardioverter-Defibrillator Functions
|
Putzke, James J. |
|
2001 |
5 |
1 |
p. 114-116 |
artikel |
19 |
Expansion of ICD Indications: Resynchronization Therapy and theICD
|
Angelo Auricchio |
|
2001 |
5 |
1 |
p. 35-39 5 p. |
artikel |
20 |
Expansion of ICD Indications: Resynchronization Therapy and the ICD
|
Auricchio, Angelo |
|
2001 |
5 |
1 |
p. 35-39 |
artikel |
21 |
Frequent Implantable Cardioverter-Defibrillator DischargesWhat Have We Learned?
|
Sven Reek |
|
2001 |
5 |
1 |
p. 121-127 7 p. |
artikel |
22 |
Frequent Implantable Cardioverter-Defibrillator Discharges—What Have We Learned?
|
Reek, Sven |
|
2001 |
5 |
1 |
p. 121-127 |
artikel |
23 |
High Defibrillation Energy Requirements: Current Management
|
Hiroshi Kasanuki |
|
2001 |
5 |
1 |
p. 62-65 4 p. |
artikel |
24 |
High Defibrillation Energy Requirements: Current Management
|
Kasanuki, Hiroshi |
|
2001 |
5 |
1 |
p. 62-65 |
artikel |
25 |
Implantable Atrioventricular Defibrillators
|
Hung-Fat Tse |
|
2001 |
5 |
1 |
p. 24-30 7 p. |
artikel |
26 |
Implantable Atrioventricular Defibrillators
|
Tse, Hung-Fat |
|
2001 |
5 |
1 |
p. 24-30 |
artikel |
27 |
Implantable Cardioverter Defibrillator Complications: Infection, Erosion,Thrombosis
|
Patricia A. Kelly |
|
2001 |
5 |
1 |
p. 109-113 5 p. |
artikel |
28 |
Implantable Cardioverter Defibrillator Complications: Infection, Erosion, Thrombosis
|
Kelly, Patricia A. |
|
2001 |
5 |
1 |
p. 109-113 |
artikel |
29 |
Implantation Techniques and Controversies
|
Steven L. Higgins |
|
2001 |
5 |
1 |
p. 58-61 4 p. |
artikel |
30 |
Implantation Techniques and Controversies
|
Higgins, Steven L. |
|
2001 |
5 |
1 |
p. 58-61 |
artikel |
31 |
Indications for Implantable Cardioverter DefibrillatorTherapy in Year 2000
|
Robert D. Lerman |
|
2001 |
5 |
1 |
p. 6-14 9 p. |
artikel |
32 |
Indications for Implantable Cardioverter Defibrillator Therapy in Year 2000
|
Lerman, Robert D. |
|
2001 |
5 |
1 |
p. 6-14 |
artikel |
33 |
Influence of the Medicare Reimbursement System onICD Implantation
|
Stephen C. Hammill |
|
2001 |
5 |
1 |
p. 133-135 3 p. |
artikel |
34 |
Influence of the Medicare Reimbursement System on ICD Implantation
|
Hammill, Stephen C. |
|
2001 |
5 |
1 |
p. 133-135 |
artikel |
35 |
Interpretation and Application of StoredElectrograms
|
Vickas V. Patel |
|
2001 |
5 |
1 |
p. 96-103 8 p. |
artikel |
36 |
Interpretation and Application of Stored Electrograms
|
Patel, Vickas V. |
|
2001 |
5 |
1 |
p. 96-103 |
artikel |
37 |
Management of Frequent or Refractory SupraventricularTachyarrhythmias in the Dual Chamber Era
|
J. Michael Mangrum |
|
2001 |
5 |
1 |
p. 79-83 5 p. |
artikel |
38 |
Management of Frequent or Refractory Supraventricular Tachyarrhythmias in the Dual Chamber Era
|
Mangrum, J. Michael |
|
2001 |
5 |
1 |
p. 79-83 |
artikel |
39 |
Optimal Programming of Adjunctive PacemakerFunctions
|
R. Hardwin Mead |
|
2001 |
5 |
1 |
p. 94-95 2 p. |
artikel |
40 |
Optimal Programming of Adjunctive Pacemaker Functions
|
Mead, R. Hardwin |
|
2001 |
5 |
1 |
p. 94-95 |
artikel |
41 |
Optimal Programming of Antitachycardia Pacing Functions
|
Mark D. Carlson |
|
2001 |
5 |
1 |
p. 90-93 4 p. |
artikel |
42 |
Optimal Programming of Antitachycardia Pacing Functions
|
Carlson, Mark D. |
|
2001 |
5 |
1 |
p. 90-93 |
artikel |
43 |
Optimal Programming of Sensing and Detection in Single-Chamber Ventricular ICDs
|
Charles D. Swerdlow |
|
2001 |
5 |
1 |
p. 84-89 6 p. |
artikel |
44 |
Optimal Programming of Sensing and Detection in Single-Chamber Ventricular ICDs
|
Swerdlow, Charles D. |
|
2001 |
5 |
1 |
p. 84-89 |
artikel |
45 |
Pharmacologic Therapy in Patients with Implantable Cardioverter-Defibrillators
|
Michael R. Lauer |
|
2001 |
5 |
1 |
p. 70-74 5 p. |
artikel |
46 |
Pharmacologic Therapy in Patients with Implantable Cardioverter-Defibrillators
|
Lauer, Michael R. |
|
2001 |
5 |
1 |
p. 70-74 |
artikel |
47 |
Risks and Benefits of Catheter Ablation of Ventricular Tachycardia in Patients with an Implantable Cardioverter-Defibrillator
|
Gregory F. Michaud |
|
2001 |
5 |
1 |
p. 75-78 4 p. |
artikel |
48 |
Risks and Benefits of Catheter Ablation of Ventricular Tachycardia in Patients with an Implantable Cardioverter-Defibrillator
|
Michaud, Gregory F. |
|
2001 |
5 |
1 |
p. 75-78 |
artikel |
49 |
Tracking ICD Performance
|
Robert G. Hauser |
|
2001 |
5 |
1 |
p. 51-57 7 p. |
artikel |
50 |
Tracking ICD Performance
|
Hauser, Robert G. |
|
2001 |
5 |
1 |
p. 51-57 |
artikel |
51 |
Understanding and Managing the Psychological Impactof the ICD
|
Jamie Beth Conti |
|
2001 |
5 |
1 |
p. 128-132 5 p. |
artikel |
52 |
Understanding and Managing the Psychological Impact of the ICD
|
Conti, Jamie Beth |
|
2001 |
5 |
1 |
p. 128-132 |
artikel |
53 |
Update: Approach to the Patient with Suspected Implantable Cardioverter-Defibrillator System Malfunction
|
Andrew E. Epstein |
|
2001 |
5 |
1 |
p. 117-120 4 p. |
artikel |
54 |
Update: Approach to the Patient with Suspected Implantable Cardioverter-Defibrillator System Malfunction
|
Epstein, Andrew E. |
|
2001 |
5 |
1 |
p. 117-120 |
artikel |
55 |
Who Should Be Implanting ICDs?
|
Steven L. Higgins |
|
2001 |
5 |
1 |
p. 66-69 4 p. |
artikel |
56 |
Who Should Be Implanting ICDs?
|
Higgins, Steven L. |
|
2001 |
5 |
1 |
p. 66-69 |
artikel |